Hot Topics June 6 2024: Highlights from the 11th Annual AARS Scientific Symposium

06/06/24 • 8 min

As part of its ongoing efforts to support research and share scientific knowledge about acne, hidradenitis suppurativa (HS), and rosacea, the American Acne and Rosacea Society (AARS) hosted its 11th Annual Scientific Symposium on May 15, 2024. The AARS was thrilled to welcome the attendees of the annual Society for Investigative Dermatology meeting to hear researchers from across the US present recent advancements in dermatological research focusing on acne, HS, and rosacea. Plus, this edition of Hot Topics in print covers a new study comparing clascoterone with retinoids and new data from the BE HEARD I and BE HEARD II studies of bimekizumab in HS.

The American Acne and Rosacea Society (AARS) is the only professional society focused on acne, hidradenitis suppurativa, and rosacea. Support AARS by becoming a member!

The American Acne and Rosacea Society (AARS) is the only professional society focused on acne, hidradenitis suppurativa, and rosacea. Support AARS by becoming a member!

Previous Episode

Hot Topics April 16 2024: Welcome the New Board of Directors

Dr. Andrea Zaenglein was recognized at the 17th Annual AARS Networking Reception in San Diego last month, as she concluded her term as AARS President. Incoming President Dr. Jim Del Rosso. Other new officers and Directors have been announced. AARS leadership past and present was well represented from the podium at the Annual Meeting of the American Academy of Dermatology (AAD) in San Diego in March. Among those presenting was Valerie Callender, MD, whose session “Lasers and Energy Devices in the Treatment of Acne” were spotlighted in Derm World Meeting News. Learn about some of the latest important research in acne, rosacea, and HS while interacting with some of the brightest young minds in the field and AARS leadership on Wednesday, May 15, 2024 from 11:00 AM –1:00 PM at the 11th Annual AARS Scientific Symposium at the 81st Annual Meeting of the Society for Investigative Dermatology at the Hilton Anatole in Dallas, Texas. Chaired by Dr. Lawrence Eichenfield. The AARS mission is to promote, support, develop and provide an educational forum for the exchange of information related to acne/HS and rosacea and to fund clinical research opportunities for dermatology professionals who strive to improve the care of patients who suffer from acne and rosacea. The deadline to submit applications is Friday, May 31, 2024.

The American Acne and Rosacea Society (AARS) is the only professional society focused on acne, hidradenitis suppurativa, and rosacea. Support AARS by becoming a member!

Next Episode

Hot Topics August 15, 2024: HS Updates, Emergency Contraception and Isotretinoin

In a new AARS video dermatologist Andrea Zaenglein, MD, FAAD and OB/Gyn Sarah K. Horvath, MD, MSHP, FACOG discuss patient counseling and recommendations for prescribing emergency contraception for patients on isotretinoin. Crown Laboratories, which owns the PanOxyl line of acne care products, plans to acquire Revance Therapeutics. New data for izokibep, a novel IL-17A inhibitor, for HS, and more.

The American Acne and Rosacea Society (AARS) is the only professional society focused on acne, hidradenitis suppurativa, and rosacea. Support AARS by becoming a member!